Effects of glucose and advanced glycation end products on oxidative stress in MIN6 cells
- PMID: 20158976
Effects of glucose and advanced glycation end products on oxidative stress in MIN6 cells
Abstract
To explore the mechanism of oxidative stress induced by glucose and advanced glycation end products (AGEs) in MIN6 cells. The MIN6 cells were exposed to various concentrations of glucose or AGEs for some time, MTT assay was used to evaluate the cell viability, reactive oxygen species (ROS) was monitored using intracellular ROS capture Dihydroethidium (DHE) and dihydrorhodamine123 (DHR123). The signal was quantified using flow cytometry by measuring the mean fluorescent intensity (MFI). The NADPH oxidase activity was measured by chemiluminescence with lucigenin. Treatment of high glucose or AGEs decreased cell viability in a dose- and time- dependent fashion. Exposure of MIN6 cells to high glucose or AGEs significantly increased intracellular ROS production in a concentration- and time- dependent manner. In parallel with the results of ROS production, the NADPH oxidase in MIN6 cells was activated due to increased glucose or AGEs concentration. High glucose and AGEs stimulated ROS production via the activation of NADPH oxidase. The oxidative stress may consequently impair pancreatic beta-cell function and contribute to diabetes mellitus as a result.
Similar articles
-
Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.Metabolism. 2006 Nov;55(11):1516-23. doi: 10.1016/j.metabol.2006.06.022. Metabolism. 2006. PMID: 17046555
-
Advanced glycation end-products induce injury to pancreatic beta cells through oxidative stress.Diabetes Metab. 2012 Jun;38(3):250-7. doi: 10.1016/j.diabet.2012.01.003. Epub 2012 Mar 3. Diabetes Metab. 2012. PMID: 22386833
-
Differential effect of sulfonylureas on production of reactive oxygen species and apoptosis in cultured pancreatic beta-cell line, MIN6.Metabolism. 2008 Aug;57(8):1038-45. doi: 10.1016/j.metabol.2008.01.038. Metabolism. 2008. PMID: 18640379
-
Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.Cardiovasc Res. 2009 Apr 1;82(1):9-20. doi: 10.1093/cvr/cvp031. Epub 2009 Jan 29. Cardiovasc Res. 2009. PMID: 19179352 Review.
-
AGE, RAGE, and ROS in diabetic nephropathy.Semin Nephrol. 2007 Mar;27(2):130-43. doi: 10.1016/j.semnephrol.2007.01.006. Semin Nephrol. 2007. PMID: 17418682 Review.
Cited by
-
Inhibition of tumor suppressor p53 preserves glycation-serum induced pancreatic beta-cell demise.Endocrine. 2016 Nov;54(2):383-395. doi: 10.1007/s12020-016-0979-5. Epub 2016 May 9. Endocrine. 2016. PMID: 27160820
-
Notoginsenoside R1 attenuates high glucose-induced endothelial damage in rat retinal capillary endothelial cells by modulating the intracellular redox state.Drug Des Devel Ther. 2017 Nov 23;11:3343-3354. doi: 10.2147/DDDT.S149700. eCollection 2017. Drug Des Devel Ther. 2017. PMID: 29200830 Free PMC article.
-
An emerging role of glucagon-like peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes.Mediators Inflamm. 2013;2013:591056. doi: 10.1155/2013/591056. Epub 2013 Jan 10. Mediators Inflamm. 2013. PMID: 23365488 Free PMC article.
-
THE EFFECT OF ADIPONECTIN VIA REGULATING THE BONE MICROENVIRONMENT OXIDATIVE STRESS ON OSTEOGENESIS IN TYPE 2 DIABETIC RATS.Acta Endocrinol (Buchar). 2021 Apr-Jun;17(2):168-176. doi: 10.4183/aeb.2021.168. Acta Endocrinol (Buchar). 2021. PMID: 34925564 Free PMC article.
-
Improving the 3D Printability of Sugar Glass to Engineer Sacrificial Vascular Templates.3D Print Addit Manuf. 2023 Oct 1;10(5):869-886. doi: 10.1089/3dp.2021.0147. Epub 2023 Oct 10. 3D Print Addit Manuf. 2023. PMID: 37886415 Free PMC article.